Integrin α1 subunit is up-regulated in colorectal cancer

Biomarker Research

Volumn 1, Issue 1, 2013, Pages

  Boudjadi, Salah ^a   Carrier, Julie C ^a   Beaulieu, Jean François ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Colorectal cancer; Immunohistochemistry staining; Integrin; QPCR; Tissue microarrays

Indexed keywords

ALPHA1 INTEGRIN;

ARTICLE; CANCER STAGING; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; UPREGULATION;

EID: 85041602061     PISSN: None     EISSN: 20507771     Source Type: Journal    
DOI: 10.1186/2050-7771-1-16     Document Type: Article

References (30)

1. Aplin AE, Juliano RL. Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J Cell Sci 1999, 112(Pt 5):695-706.
2. Giancotti FG. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997, 9:691-700. 10.1016/S0955-0674(97)80123-8, 9330873.
3. Lock R, Debnath J. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 2008, 20:583-588. 10.1016/j.ceb.2008.05.002, 2613490, 18573652.
4. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010, 10:9-22.
5. Beaulieu JF. Integrin alpha6beta4 in colorectal cancer. World J Gastrointest Pathophysiol 2010, 1:3-11. 10.4239/wjd.v1.i1.3, 3097941, 21607137.
6. Teller IC, Beaulieu JF. Interactions between laminin and epithelial cells in intestinal health and disease. Expert Rev Mol Med 2001, 3:1-18.
7. Basora N, Desloges N, Chang Q, Bouatrouss Y, Gosselin J, Poisson J, Sheppard D, Beaulieu JF. Expression of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int J Cancer 1998, 75:738-743. 10.1002/(SICI)1097-0215(19980302)75:5<738::AID-IJC12>3.0.CO;2-2, 9495242.
8. Dydensborg AB, Teller IC, Groulx JF, Basora N, Pare F, Herring E, Gauthier R, Jean D, Beaulieu JF. Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity. BMC Cancer 2009, 9:223. 10.1186/1471-2407-9-223, 2715428, 19586553.
9. Ni H, Dydensborg AB, Herring FE, Basora N, Gagne D, Vachon PH, Beaulieu JF. Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression. Oncogene 2005, 24:6820-6829. 10.1038/sj.onc.1208848, 16007143.
10. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010, 339:269-280. 10.1007/s00441-009-0834-6, 2784866, 19693543.
11. Gardner H. Integrin α1β1. I domains in integrins 2003, 25-39. New York: Kluwer Academic/Plenum: Molecular Biology Intelligence Unit.
12. Beaulieu JF. Differential expression of the VLA family of integrins along the crypt-villus axis in the human small intestine. J Cell Sci 1992, 102(Pt 3):427-436.
13. Lussier C, Basora N, Bouatrouss Y, Beaulieu JF. Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa [In Process Citation]. MicroscResTech 2000, 51:169-178.
14. Giancotti FG. Complexity and specificity of integrin signalling. Nat Cell Biol 2000, 2:E13-E14. 10.1038/71397, 10620816.
15. Francoeur C, Bouatrouss Y, Seltana A, Pinchuk IV, Vachon PH, Powell DW, Sawan B, Seidman EG, Beaulieu JF. Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. Gastroenterology 2009, 136:268-277. e263, 10.1053/j.gastro.2008.10.014, 18976656.
16. Lochter A, Navre M, Werb Z, Bissell MJ. alpha1 And alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell 1999, 10:271-282. 25168, 9950676.
17. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res 2003, 63:8312-8317.
18. Fukuda K, Saikawa Y, Yagi H, Wada N, Takahashi T, Kitagawa Y. Role of integrin alpha1 subunits in gastric cancer patients with peritoneal dissemination. Mol Med Report 2012, 5:336-340.
19. Van Slambrouck S, Grijelmo C, De Wever O, Bruyneel E, Emami S, Gespach C, Steelant WF. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. Int J Oncol 2007, 31:1501-1508.
20. Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A 2000, 97:2202-2207. 10.1073/pnas.040378497, 15778, 10681423.
21. Macias-Perez I, Borza C, Chen X, Yan X, Ibanez R, Mernaugh G, Matrisian LM, Zent R, Pozzi A. Loss of integrin alpha1beta1 ameliorates kras-induced lung cancer. Cancer Res 2008, 68:6127-6135. 10.1158/0008-5472.CAN-08-1395, 2801028, 18676835.
22. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, Minna JD. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006, 66:2116-2128. 10.1158/0008-5472.CAN-05-2521, 16489012.
23. Lievre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, Cote JF, Tomasic G, Penna C, Ducreux M. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006, 66:3992-3995. 10.1158/0008-5472.CAN-06-0191, 16618717.
24. Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 2012, 486:532-536.
25. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts Are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147. 10.1016/j.ccr.2009.12.041, 20138012.
26. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406. 10.1016/j.ccr.2008.03.007, 18455123.
27. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007, 9:1392-1400. 10.1038/ncb1658, 18037882.
28. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906. 10.1016/j.cell.2009.10.027, 2788004, 19931152.
29. Chen N, Zhou Q. Constructing tissue microarrays without prefabricating recipient blocks: a novel approach. Am J Clin Pathol 2005, 124:103-107. 10.1309/LHCJRFBUH8Q6QD3N, 15923162.
30. Dydensborg AB, Herring E, Auclair J, Tremblay E, Beaulieu JF. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1067-G1074.